23
Open Letter to Dr. Josephine Briggs
Filed Under (Health Care) by Admin on 23-07-2010
Josephine P. Briggs, M.D.
Director, National Center for Complementary and Alternative Medicine
Dear Dr. Briggs,
23
Josephine P. Briggs, M.D.
Director, National Center for Complementary and Alternative Medicine
Dear Dr. Briggs,
21
What is really worth reading here are the comments under the area of culture shock with Microsoft talking about how long a project stays in the works, no more than2 to 2/2 years and this was a shock to government workers as they have had long slow drag outs for implementing new
applications and software, not to mention hardware too.
21
I have seen some unfair and unreasonable admission agreements prepared by nursing homes…but the agreements now used by Trinity Mission take the cake!
21
21
First of all finding fake store fronts is a good idea and something has never been researched to any large degree. Florida is a huge area for fraud.
Crooks are better billers so you cant rely on electronic monitoring only as all their data looks perfect as they have one focus of fraud and do not see patients. One other big area was dead doctors who were rolling in their graves submitting claims. This was a disconnect of data systems to where authenticity was not being conducted by Medicare.
20
Prior to Blue Cross she worked at Kaiser Permanente as a chief operations leader and with Cigna for 13 years as President and General manager of Cigna of California in their legal department. I wonder how well she knew Wendell Potter who left Cigna a couple years ago and became the whistle
blower of the health insurance industry.
20
At an interview of Barry Chaiken, MD, MPH, FHIMSS, former Chairman of the Board of health IT trade group HIMSS and chief medical officer of Imprivata, a company specializing in healthcare IT security, Chaiken pleads for the following special accommodations for Health IT relative to other medical sectors:
19
Heres one more problem for Avandia, will it survive? BD
CBS News has learned that the Indian government has ordered Glaxo Smith Kline to suspend 19 drug trials in India for the controversial
diabetes drug Avandia because of recently released studies showing potential heart problems with the drug. The trial continues at over 300 locations worldwide.
19
A Denver Post article offered a brief glimpse into the health benefits of corporate leaders, on the unusual occasion of a former CEO now in legal fight for the health benefits in the style to which he had become accustomed:
Read the rest of this entry »
19